Found: 25
Select item for more details and to access through your institution.
The effect of spironolactone on cardiovascular function and markers of fibrosis in people at increased risk of developing heart failure: the heart 'OMics' in AGEing (HOMAGE) randomized clinical trial.
- Published in:
- European Heart Journal, 2021, v. 42, n. 6, p. 684, doi. 10.1093/eurheartj/ehaa758
- By:
- Publication type:
- Article
Thromboembolic event rate in paroxysmal and persistent atrial fibrillation: Data from the GISSI-AF trial.
- Published in:
- BMC Cardiovascular Disorders, 2013, v. 13, n. 1, p. 1, doi. 10.1186/1471-2261-13-28
- By:
- Publication type:
- Article
Thromboembolic event rate in paroxysmal and persistent atrial fibrillation: data from the GISSI-AF trial.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Le quindici medicine. Quale ci salverà?
- Published in:
- Il Cesalpino, 2021, n. 53, p. 39
- By:
- Publication type:
- Article
Il dottore e il paziente: Come ricreare il rapporto di fiducia che avevamo con il medico di una volta.
- Published in:
- Il Cesalpino, 2021, n. 53, p. 38
- By:
- Publication type:
- Article
Clinical outcome of renal tubular damage in chronic heart failure†.
- Published in:
- European Heart Journal, 2011, v. 32, n. 21, p. 2705, doi. 10.1093/eurheartj/ehr190
- By:
- Publication type:
- Article
Effects of rosuvastatin on atrial fibrillation occurrence: ancillary results of the GISSI-HF trial.
- Published in:
- European Heart Journal, 2009, v. 30, n. 19, p. 2327
- By:
- Publication type:
- Article
Spironolactone effect on cardiac structure and function of patients with heart failure and preserved ejection fraction: a pooled analysis of three randomized trials.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 1, p. 108, doi. 10.1002/ejhf.2726
- By:
- Publication type:
- Article
The association between markers of type I collagen synthesis and echocardiographic response to spironolactone in patients at risk of heart failure: findings from the HOMAGE trial.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 9, p. 1559, doi. 10.1002/ejhf.2579
- By:
- Publication type:
- Article
Influence of ejection fraction on biomarker expression and response to spironolactone in people at risk of heart failure: findings from the HOMAGE trial.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 5, p. 771, doi. 10.1002/ejhf.2455
- By:
- Publication type:
- Article
Biomarker‐based assessment of collagen cross‐linking identifies patients at risk of heart failure more likely to benefit from spironolactone effects on left atrial remodelling. Insights from the HOMAGE clinical trial.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 2, p. 321, doi. 10.1002/ejhf.2394
- By:
- Publication type:
- Article
Effects of spironolactone on serum markers of fibrosis in people at high risk of developing heart failure: rationale, design and baseline characteristics of a proof‐of‐concept, randomised, precision‐medicine, prevention trial. The Heart OMics in AGing (HOMAGE) trial
- Published in:
- European Journal of Heart Failure, 2020, v. 22, n. 9, p. 1711, doi. 10.1002/ejhf.1716
- By:
- Publication type:
- Article
Insulin treatment and clinical outcomes in patients with diabetes and heart failure with preserved ejection fraction.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Risk stratification according to insulin type: reply.
- Published in:
- 2018
- By:
- Publication type:
- Letter
Treatment with insulin is associated with worse outcome in patients with chronic heart failure and diabetes.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Initiating sacubitril/valsartan (LCZ696) in heart failure: results of TITRATION, a double-blind, randomized comparison of two uptitration regimens.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Proteomic mechanistic profile of patients with diabetes at risk of developing heart failure: insights from the HOMAGE trial.
- Published in:
- Cardiovascular Diabetology, 2021, v. 20, n. 1, p. 1, doi. 10.1186/s12933-021-01357-9
- By:
- Publication type:
- Article
The shared decision-making process in stable angina From ARCA Registry to ORBITA 1 and 2, through ISCHEMIA and ISCHEMIA Extended.
- Published in:
- Outpatient Cardiology / Cardiologia Ambulatorial, 2023, v. 31, n. 4, p. 1
- By:
- Publication type:
- Article
Riflessioni su "Arca Registry for Chronic Angina".
- Published in:
- Outpatient Cardiology / Cardiologia Ambulatorial, 2022, v. 30, n. 1, p. 57, doi. 10.17473/1971-6818-2022-1-13
- By:
- Publication type:
- Article
Te linee guida: la difficile applicazione tra clinica, scienza, giurisprudenza, sostenibilità economica ed organizzativa.
- Published in:
- Outpatient Cardiology / Cardiologia Ambulatorial, 2021, v. 29, n. 2, p. 1
- By:
- Publication type:
- Article
Phenotyping patients with ischaemic heart disease at risk of developing heart failure: an analysis of the HOMAGE trial.
- Published in:
- ESC Heart Failure, 2024, v. 11, n. 1, p. 209, doi. 10.1002/ehf2.14465
- By:
- Publication type:
- Article
Dyskalemia in people at increased risk for heart failure: findings from the heart 'OMics' in AGEing (HOMAGE) trial.
- Published in:
- ESC Heart Failure, 2022, v. 9, n. 6, p. 4352, doi. 10.1002/ehf2.14086
- By:
- Publication type:
- Article
Stable atypical chest pain with negative anatomical or functional diagnostic test: Diagnosis no matter what or prevention at any cost?
- Published in:
- Clinical Cardiology, 2019, v. 42, n. 10, p. 982, doi. 10.1002/clc.23250
- By:
- Publication type:
- Article
Prognostic Impact of Diabetes and Prediabetes on Survival Outcomes in Patients With Chronic Heart Failure: A Post-Hoc Analysis of the GISSI-HF (Gruppo Italiano per lo Studio della Sopravvivenza nella Insufficienza Cardiaca-Heart Failure) Trial.
- Published in:
- Journal of the American Heart Association, 2017, v. 6, n. 7, p. 1, doi. 10.1161/JAHA.116.005156
- By:
- Publication type:
- Article
Biomarker-based assessment of collagen cross-linking identifies patients at risk of heart failure more likely to benefit from spironolactone effects on left atrial remodelling. Insights from the HOMAGE clinical trial.
- Published in:
- European Journal of Heart Failure. Supplements, 2022, v. 24, n. 2, p. 321, doi. 10.1002/ejhf.2394
- By:
- Publication type:
- Article